Get started
Author

Emmanuelle Wilhelm

Observed names: E Wilhelm, E. Wilhelm, Emmanuelle, Wilhelm, Wilhelm, Emmanuelle
Observed institutions: Centre National de la Recherche Scientifique, Université de Sherbrooke, Inserm, Centre Hospitalier Universitaire de Sherbrooke, Institut de génétique et de biologie moléculaire et cellulaire, OSE Immunotherapeutics (France), Centre de recherche du CHUS, Université de Strasbourg
ORCID: 0000-0003-2506-2892
Observed ORCID: 0000-0003-2506-2892
OpenAlex ID: A5022705054
Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of Acute Myeloid Leukemia by Protein Kinase A–Mediated Desubordination of Retinoid X Receptor
2005 · Lucia Altucci, Aurélie Rossin, et al. · Cancer Research · 120
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
2020 · Vanessa Gauttier, Sabrina Pengam, et al. · Journal of Clinical Investigation · 84
PDF
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication
2016 · Lulzim Shkreta, Marco Blanchette, et al. · Nucleic Acids Research · 48
PDF
HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription
2013 · Sebastian Eilebrecht, Emmanuelle Wilhelm, et al. · RNA Biology · 27
PDF
Regulation of nuclear receptor and cofactor expression in breast cancer cell lines
2003 · A Vienonen, S Miettinen, et al. · European Journal of Endocrinology · 26
CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy
2022 · Marion Drouin, Javier Saenz, et al. · Science Advances · 25
PDF
Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A
2018 · Ian Tietjen, David E. Williams, et al. · Antiviral Research · 24
CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes
2012 · Emmanuelle Wilhelm, Marie-Christine Doyle, et al. · Retrovirology · 23
PDF
Leukemia: beneficial actions of retinoids and rexinoids
2003 · Lucia Altucci, Emmanuelle Wilhelm, et al. · The International Journal of Biochemistry & Cell Biology · 23
Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine
2020 · V. Gauttier, A. Morello, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 18
PDF
TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53
2010 · Emmanuelle Wilhelm, Mara Kornete, et al. · BMC Molecular Biology · 16
PDF
TAF6δ Controls Apoptosis and Gene Expression in the Absence of p53
2008 · Emmanuelle Wilhelm, François-Xavier Pellay, et al. · PLoS ONE · 14
PDF
Nf-κb-Dependent Inhibition of HIV-1 Transcription by Withaferin A
2017 · Tao Shi, Emmanuelle Wilhelm, et al. · HIV Current Research · 11
BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis
2018 · Aurélie Delannoy, Emmanuelle Wilhelm, et al. · Cell Death and Disease · 10
PDF
Determining the impact of alternative splicing events on transcriptome dynamics
2008 · Emmanuelle Wilhelm, François-Xavier Pellay, et al. · BMC Research Notes · 10
PDF
Alternative Splicing of TAF6: Downstream Transcriptome Impacts and Upstream RNA Splice Control Elements
2014 · Catherine Kamtchueng, Marie-Éve Stébenne, et al. · PLoS ONE · 8
PDF
CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury
2024 · Camille Ligeron, Javier Saenz, et al. · The Journal of Immunology · 7
Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression
2024 · Emmanuelle Wilhelm, Mikaël Poirier, et al. · PLoS Pathogens · 6
Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency
2013 · Emmanuelle Wilhelm, Brendan Bell · Current Opinion in Virology · 5
Probing Endogenous RNA Polymerase II Pre-initiation Complexes by Electrophoretic Mobility Shift Assay
2011 · Emmanuelle Wilhelm, Christopher Takacs, et al. · Methods in molecular biology · 5
Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement.
2001 · Fabien Guidez, Lucia Altucci, et al. · Research Portal (King's College London) · 3
1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy
2023 · Aurore Morello, Justine Durand, et al. · Journal for ImmunoTherapy of Cancer · 2
PDF
Abstract 3259: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy controlling damaged and tumor cells phagocytosis
2020 · Vanessa Gauttier, Marion Drouin, et al. · Cancer Research · 1
Abstract 7293: First in class Anti-CLEC-1A myeloid checkpoint antibodies for the treatment of solid tumors with monotherapy and combination therapy efficacies
2025 · Etienne Foucher, Mylène Deramé, et al. · Cancer Research
Abstract 6342: Anti-tumor in vivo efficacy of different classes of anti-CLEC-1 myeloid checkpoint antibodies in monotherapy and in combination with chemotherapeutic agents
2024 · Aurore Morello, Mylène Deramé, et al. · Cancer Research
Works count: 39
Citation count: 516
H-index: 12
I10-index: 15
Year
Topic
Type